Cornea Surgeon at Swedish Medical Center Successfully Implants FDA-Approved Telescope for Macular Degeneration
SEATTLE – October 28, 2013 – Dr. Thomas Gillette, cornea surgeon at Swedish Medical Center and Eye Associates Northwest, P.C. in Seattle, Wash. successfully implanted a tiny telescope into the eye of an end-stage macular degeneration (AMD) patient. The patient, 76-year-old Charles DePoe, had his surgery in October 2012 at Swedish. DePoe is a resident of Kennewick, Wash. and is the first and only in the state to have received the telescope implant. DePoe, who had lost nearly all of his central vision, set a goal with his surgeon, Dr. Gillette, for the implant. He wished to gain enough of his central vision back to once again recognize his wife’s face and read the newspaper.
“We know the impact the telescope technology can have on a patient’s life. We are excited to finally be able to offer this technology on a broader basis and to be one of the first provider teams in the Pacific Northwest to help patients improve their vision and achieve a greater quality of life,” says Dr. Gillette. “More than 15 million Americans are affected by some form of AMD, and it is the leading cause of blindness in older Americans.”
Information from Swedish on Multistate Fungal Meningitis Outbreak among Patients who Received Contaminated Steroid Injections
SEATTLE, Oct. 23, 2012 – The U.S. Food and Drug Administration (FDA) is investigating a multistate outbreak of fungal meningitis and joint infections. It appears the outbreak is due to the contamination of an injectable steroid medication called methylprednisolone acetate produced by the New England Compounding Center (NECC). Swedish has never carried the methylprednisolone acetate product produced by NECC.
More information about the Swedish newsroom
Explore the rest of the Swedish blog
Swedish has a social media policy
See who is blogging at Swedish
Check out more from Swedish:
See who else is blogging at Swedish